Phibro Animal Health (PAHC) Change in Accured Expenses (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Change in Accured Expenses of $361000.0 for Q1 2026, up 281.41% year-over-year from $94649.5 in Q1 2025, and down 96.73% quarter-over-quarter from $11.0 million in Q4 2025.
Phibro Animal Health (PAHC) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Phibro Animal Health's Change in Accured Expenses history runs 14 years deep, the most recent figure standing at $361000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 281.41% year-over-year to $361000.0; the TTM figure through Mar 2026 stood at $23.8 million (down 21.48% YoY), while the FY2025 annual figure was $47.2 million, up 286.9% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $361000.0, down from $11.0 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $26.1 million in Q2 2025, with the low at -$13.7 million in Q3 2025.
- The 5-year median for Change in Accured Expenses is $361000.0 (2026), against an average of $3.3 million.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses soared 1357.99% in 2024, then sank 288.42% in 2025.
- Phibro Animal Health's Change in Accured Expenses stood at $6.0 million in 2022, then jumped by 36.38% to $8.2 million in 2023, then surged by 202.8% to $24.8 million in 2024, then plunged by 55.48% to $11.0 million in 2025, then tumbled by 96.73% to $361000.0 in 2026.
- Business Quant data shows PAHC's Change in Accured Expenses at $361000.0 in Q1 2026, $11.0 million in Q4 2025, and -$13.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 361,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 361,000.00 |
| Mar 31, 2026 | 361,000.00 |
| Dec 31, 2025 | 11.03 Mn |
| Dec 31, 2025 | 11.03 Mn |
| Sep 30, 2025 | -13.69 Mn |
| Sep 30, 2025 | -13.69 Mn |
| Jun 30, 2025 | 26.12 Mn |
| Jun 30, 2025 | 26.12 Mn |
| Mar 31, 2025 | -199,000.00 |
| Mar 31, 2025 | -199,000.00 |
| Dec 31, 2024 | 24.77 Mn |
| Dec 31, 2024 | 24.77 Mn |
| Sep 30, 2024 | -3.52 Mn |
| Sep 30, 2024 | -3.52 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Mar 31, 2024 | 530,000.00 |
| Mar 31, 2024 | 530,000.00 |
| Dec 31, 2023 | 8.18 Mn |
| Dec 31, 2023 | 8.18 Mn |